Sung Choe

10.3k total citations · 1 hit paper
48 papers, 1.8k citations indexed

About

Sung Choe is a scholar working on Molecular Biology, Hematology and Cancer Research. According to data from OpenAlex, Sung Choe has authored 48 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 20 papers in Hematology and 17 papers in Cancer Research. Recurrent topics in Sung Choe's work include Acute Myeloid Leukemia Research (18 papers), Cancer Genomics and Diagnostics (10 papers) and Cancer, Hypoxia, and Metabolism (7 papers). Sung Choe is often cited by papers focused on Acute Myeloid Leukemia Research (18 papers), Cancer Genomics and Diagnostics (10 papers) and Cancer, Hypoxia, and Metabolism (7 papers). Sung Choe collaborates with scholars based in United States, France and Germany. Sung Choe's co-authors include George M. Church, Marc S. Halfon, Alan D. Michelson, Michael Boutros, Marion Dorsch, Stefan Größ, Sébastien Michaud, Scott A. Biller, Jeremy Travins and Joshua Murtie and has published in prestigious journals such as Journal of Biological Chemistry, Nature Medicine and Journal of Clinical Oncology.

In The Last Decade

Sung Choe

48 papers receiving 1.8k citations

Hit Papers

Vorasidenib and ivosidenib in IDH1-mutant low-grade gliom... 2023 2026 2024 2025 2023 25 50 75 100

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sung Choe United States 20 1.1k 345 243 183 165 48 1.8k
Adriana Aguilar‐Mahecha Canada 19 835 0.8× 637 1.8× 420 1.7× 270 1.5× 169 1.0× 43 1.7k
Carsten Hagemann Germany 26 1.1k 1.0× 419 1.2× 404 1.7× 320 1.7× 142 0.9× 74 2.0k
Susanne N. Weber Germany 22 1.1k 1.0× 219 0.6× 205 0.8× 77 0.4× 116 0.7× 68 2.0k
Michael Leserer Germany 4 1.2k 1.1× 213 0.6× 576 2.4× 92 0.5× 139 0.8× 4 1.9k
Pierre de la Grange France 34 2.2k 2.0× 630 1.8× 462 1.9× 196 1.1× 163 1.0× 93 3.2k
Bruce D. Cuevas United States 19 1.5k 1.3× 308 0.9× 430 1.8× 109 0.6× 84 0.5× 25 2.1k
Michaela Gruber Austria 15 929 0.9× 661 1.9× 138 0.6× 160 0.9× 103 0.6× 30 1.6k
Simona Romano Italy 28 1.3k 1.2× 259 0.8× 528 2.2× 159 0.9× 142 0.9× 89 2.2k
Shivapriya Ramaswamy United States 9 2.2k 2.0× 324 0.9× 457 1.9× 206 1.1× 165 1.0× 12 2.5k

Countries citing papers authored by Sung Choe

Since Specialization
Citations

This map shows the geographic impact of Sung Choe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sung Choe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sung Choe more than expected).

Fields of papers citing papers by Sung Choe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sung Choe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sung Choe. The network helps show where Sung Choe may publish in the future.

Co-authorship network of co-authors of Sung Choe

This figure shows the co-authorship network connecting the top 25 collaborators of Sung Choe. A scholar is included among the top collaborators of Sung Choe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sung Choe. Sung Choe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
DiNardo, Courtney D., Stéphane de Botton, Daniel A. Pollyea, et al.. (2023). Safety, efficacy, and PK/PD of vorasidenib in previously treated patients with mIDH1/2 hematologic malignancies: A phase 1 study. American Journal of Hematology. 98(9). E233–E236. 5 indexed citations
2.
Mellinghoff, Ingo K., Min Lu, Patrick Y. Wen, et al.. (2023). Vorasidenib and ivosidenib in IDH1-mutant low-grade glioma: a randomized, perioperative phase 1 trial. Nature Medicine. 29(3). 615–622. 111 indexed citations breakdown →
3.
DiNardo, Courtney D., Eytan M. Stein, Arnaud Pigneux, et al.. (2021). Outcomes of patients with IDH1-mutant relapsed or refractory acute myeloid leukemia receiving ivosidenib who proceeded to hematopoietic stem cell transplant. Leukemia. 35(11). 3278–3281. 9 indexed citations
4.
Choe, Sung, Hongfang Wang, Courtney D. DiNardo, et al.. (2019). Molecular Mechanisms Mediating Relapse Following Ivosidenib Monotherapy in Patients with IDH1-Mutant Relapsed or Refractory Acute Myeloid Leukemia. Blood. 134(Supplement_1). 545–545. 4 indexed citations
5.
Stone, Richard M., Sung Choe, Vickie Zhang, et al.. (2017). Genetic Profiling and Deep IDH1 Mutation Clearance to ≤0.04% in Ivosidenib (AG-120)-Treated Patients with Mutant IDH1 Relapsed or Refractory and Untreated AML. Blood. 130. 2684–2684. 1 indexed citations
6.
Allen, Eric L., Danielle Ulanet, David Pirman, et al.. (2016). Differential Aspartate Usage Identifies a Subset of Cancer Cells Particularly Dependent on OGDH. Cell Reports. 17(3). 876–890. 53 indexed citations
7.
Marjon, Katya, Michael J. Cameron, Phong Quang, et al.. (2016). MTAP Deletions in Cancer Create Vulnerability to Targeting of the MAT2A/PRMT5/RIOK1 Axis. Cell Reports. 15(3). 574–587. 280 indexed citations
8.
Ulanet, Danielle, Abhishek Jha, Sung Choe, et al.. (2014). Mesenchymal Phenotype Predisposes Lung Cancer Cells to Impaired Proliferation and Redox Stress in Response to Glutaminase Inhibition. PLoS ONE. 9(12). e115144–e115144. 39 indexed citations
9.
Wang, Fang, Jeremy Travins, Yue Chen, et al.. (2014). Abstract 3116: AG-221 offers a survival advantage in a primary human IDH2 mutant AML xenograft model. Cancer Research. 74(19_Supplement). 3116–3116. 6 indexed citations
10.
Seyhan, Attila A., et al.. (2012). A genome-wide RNAi screen identifies novel targets of neratinib resistance leading to identification of potential drug resistant genetic markers. Molecular BioSystems. 8(5). 1553–1570. 29 indexed citations
11.
Jumlongras, Dolrudee, Salil A. Lachke, Daniel J. O’Connell, et al.. (2012). An Evolutionarily Conserved Enhancer Regulates Bmp4 Expression in Developing Incisor and Limb Bud. PLoS ONE. 7(6). e38568–e38568. 19 indexed citations
12.
Berasi, Stephen P., Yan Liu, Ying Zhang, et al.. (2012). Estrogen-related receptor α regulates osteoblast differentiation via Wnt/β-catenin signaling. Journal of Molecular Endocrinology. 48(2). 177–191. 45 indexed citations
13.
Schack, David von, Michael Agostino, Yizheng Li, et al.. (2011). Dynamic Changes in the MicroRNA Expression Profile Reveal Multiple Regulatory Mechanisms in the Spinal Nerve Ligation Model of Neuropathic Pain. PLoS ONE. 6(3). e17670–e17670. 123 indexed citations
14.
Choe, Sung, et al.. (2010). An in silico analysis of microRNAs: Mining the miRNAome. Molecular BioSystems. 6(10). 1853–1862. 27 indexed citations
15.
Messersmith, Wells A., N.V. Rajeshkumar, Aik Choon Tan, et al.. (2009). Efficacy and pharmacodynamic effects of bosutinib (SKI-606), a Src/Abl inhibitor, in freshly generated human pancreas cancer xenografts. Molecular Cancer Therapeutics. 8(6). 1484–1493. 34 indexed citations
16.
Crabtree, Judy S., Scott A. Jelinsky, Heather A. Harris, et al.. (2009). Comparison of Human and Rat Uterine Leiomyomata: Identification of a Dysregulated Mammalian Target of Rapamycin Pathway. Cancer Research. 69(15). 6171–6178. 83 indexed citations
17.
Henderer, Jeffrey, et al.. (2008). Comparison of Single Thickness and Double Thickness Processed Pericardium Patch Graft in Glaucoma Drainage Device Surgery. Journal of Glaucoma. 17(1). 48–51. 59 indexed citations
18.
Jelinsky, Scott A., Sung Choe, Judy S. Crabtree, et al.. (2008). Molecular analysis of the vaginal response to estrogens in the ovariectomized rat and postmenopausal woman. BMC Medical Genomics. 1(1). 27–27. 17 indexed citations
19.
Choe, Sung, Michael Boutros, Alan D. Michelson, George M. Church, & Marc S. Halfon. (2005). Preferred analysis methods for Affymetrix GeneChips revealed by a wholly defined control dataset. Genome biology. 6(2). R16–R16. 294 indexed citations
20.
Choe, Sung, Lewyn Li, Paul Matsudaira, Gerhard Wagner, & Eugene I. Shakhnovich. (2000). Differential stabilization of two hydrophobic cores in the transition state of the villin 14T folding reaction 1 1Edited by A. Fersht. Journal of Molecular Biology. 304(1). 99–115. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026